Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection
NCT ID: NCT03123042
Last Updated: 2025-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
243 participants
INTERVENTIONAL
2017-03-20
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Contents: The number of enrollment is 247 patients. The patients underwent endoscopic resection for early gastric cancer, and the tumor was defined to be out of indication for endoscopic resection pathologically. So, additional gastrectomy is recommended for them.
The investigators will enroll patients who agree this study. After general anesthesia, Tc99m-Phytate with indocyanine green will be injected with endoscopy. Then sentinel basin will be detected using gamma probe and laparoscopic basin dissection will be done. Sentinel lymph node will be identify in back table dissection, and patients will undergo conventional gastrectomy. Detection rate and false negative rate will be evaluated by pathological review.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer
NCT05892289
Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)
NCT05978882
Clinical Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer
NCT03313700
Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer
NCT03314649
Efficacy of RUS GA Surgical Navigation for Robot-assisted Distal Gastrectomy in Gastric Cancer Patients
NCT06639490
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. endoscopic tracer injection after general anesthesia
2. Tracer : Tc99m-phytate 3cc and indocyanine green 3cc mix --\> Injection of the probe (1cc/site, 4 sites) around endoscopic submucosal dissection ulcer scar
3. Sentinel basin identification with laparoscopic probe
4. Dissection of the sentinel basin
5. Sentinel node dissection at back table
6. Conventional laparoscopic gastrectomy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sentinel basin dissection
Intervention: Sentinel basin dissection
Sentinel basin dissection
Sentinel basin detection using endoscopic detector (Tc99m plus indocyanine green) injection and laparoscopic sentinel basin dissection. Then conventional gastrectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sentinel basin dissection
Sentinel basin detection using endoscopic detector (Tc99m plus indocyanine green) injection and laparoscopic sentinel basin dissection. Then conventional gastrectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who underwent endoscopic submucosal dissection and the tumor was defined as out of indication.
The expanded criteria for endoscopic resection are as follows
* criterion I: intramucosal tumor without ulcerative findings and of differentiated type with size \> 2 cm
* criterion II: intramucosal tumor with ulcerative findings and of differentiated type with size ≤ 3 cm
* criterion III: intramucosal tumor without ulcerative findings and of undifferentiated type with size \< 2 cm
* criterion IV, submucosal invasion \< 500 mm and of differentiated type with size ≤ 3 cm)
* Eastern Cooperative Oncology Group (ECOG) performance scale 0 or 1
Exclusion Criteria
* Pregnant
* Patients who had previous gastric surgery
* Patients who had previous upper abdomen surgery except cholecystectomy, or radiation therapy on upper abdomen, or hypersensitivity to any medicine
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Center, Korea
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bang Wool Eom
Staff surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bang Wool Eom, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
National Cancer Center, Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bang Wool Eom
Goyang-si, Gyeonggi-do, South Korea
Soonchunhyang University College of Medicine
Bucheon-si, , South Korea
Dongnam Institute of Radiological and Medical Science
Busan, , South Korea
Gyeongsang National University Changwon Hospital
Changwon, , South Korea
Kyungpook National University Medical Center
Daegu, , South Korea
Chonnam National University Hwasun Hospital
Hwasun, , South Korea
Gyeongsang National University Hospital
Jinju, , South Korea
Samsung Medical Center
Seoul, , South Korea
Ajou University School of Medicine
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Eom BW, Yoon HM, Min JS, Cho I, Park JH, Jung MR, Hur H, Kim YW, Park YK, Nam BH, Ryu KW; Sentinel Node Oriented Tailored Approach (SENORITA) Study Group. Prospective Multicenter Feasibility Study of Laparoscopic Sentinel Basin Dissection after Endoscopic Submucosal Dissection for Early Gastric Cancer: SENORITA 2 Trial Protocol. J Gastric Cancer. 2019 Jun;19(2):157-164. doi: 10.5230/jgc.2019.19.e12. Epub 2019 Apr 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1710162
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.